137 related articles for article (PubMed ID: 33665869)
41. Mononuclear cell collection for extracorporeal photopheresis: Concentrate characteristics for off-line UV-A irradiation procedure.
Piccirillo N; Putzulu R; Massini G; Fiore AG; Chiusolo P; Sica S; Zini G
J Clin Apher; 2018 Jun; 33(3):217-221. PubMed ID: 28833438
[TBL] [Abstract][Full Text] [Related]
42. In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis.
Coppard C; Hannani D; Humbert M; Gauthier V; Plumas J; Merlin E; Gabert F; Chaperot L
J Clin Apher; 2019 Aug; 34(4):450-460. PubMed ID: 30860623
[TBL] [Abstract][Full Text] [Related]
43. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis.
George JF; Gooden CW; Guo L; Kirklin JK
J Heart Lung Transplant; 2008 Jun; 27(6):616-22. PubMed ID: 18503960
[TBL] [Abstract][Full Text] [Related]
44. Photopheresis up-regulates CD36 on monocytes and reduces CD25(+) and CD28(+) T cell numbers.
Bladon J; Taylor PC
Photodiagnosis Photodyn Ther; 2005 Jun; 2(2):119-27. PubMed ID: 25048671
[TBL] [Abstract][Full Text] [Related]
45. Extracorporeal photopheresis: a review.
Oliven A; Shechter Y
Blood Rev; 2001 Jun; 15(2):103-8. PubMed ID: 11409910
[TBL] [Abstract][Full Text] [Related]
46. Indication-specific immunomodulatory effects of extracorporeal photopheresis: A pilot study in heart transplanted patients.
Dieterlen MT; Garbade J; Misfeld M; Lehmann S; Klaeske K; Borger MA; Barten MJ
J Clin Apher; 2018 Oct; 33(5):591-599. PubMed ID: 30176056
[TBL] [Abstract][Full Text] [Related]
47. Extracorporeal photopheresis as an immunomodulatory agent: Haematocrit-dependent effects on natural killer cells.
Becherucci V; Allegro E; Brugnolo F; Piccini L; Gori V; Bisin S; Bindi B; Ceccantini R; Pavan P; Cunial V; Gentile F; Ermini S; Bambi F
J Clin Apher; 2017 Aug; 32(4):257-265. PubMed ID: 27476149
[TBL] [Abstract][Full Text] [Related]
48. In vitro treatment of monocytes with 8-methoxypsolaren and ultraviolet A light induces dendritic cells with a tolerogenic phenotype.
Legitimo A; Consolini R; Failli A; Fabiano S; Bencivelli W; Scatena F; Mosca F
Clin Exp Immunol; 2007 Jun; 148(3):564-72. PubMed ID: 17386076
[TBL] [Abstract][Full Text] [Related]
49. Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease.
Franklin C; Cesko E; Hillen U; Schilling B; Brandau S
PLoS One; 2015; 10(8):e0134518. PubMed ID: 26241482
[TBL] [Abstract][Full Text] [Related]
50. The assessment of immune-regulatory effects of extracorporeal photopheresis in systemic sclerosis: a long-term follow-up study.
Papp G; Horvath IF; Gyimesi E; Barath S; Vegh J; Szodoray P; Zeher M
Immunol Res; 2016 Apr; 64(2):404-11. PubMed ID: 26168768
[TBL] [Abstract][Full Text] [Related]
51. Experimental extracorporeal photopheresis therapy significantly delays the development of diabetes in non-obese diabetic mice.
Xia CQ; Chernatynskaya A; Lai Y; Campbell KA; Clare-Salzler MJ
Clin Immunol; 2010 Jun; 135(3):374-83. PubMed ID: 20223712
[TBL] [Abstract][Full Text] [Related]
52. Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis.
Tambur AR; Ortegel JW; Morales A; Klingemann H; Gebel HM; Tharp MD
Transplant Proc; 2000 Jun; 32(4):747-8. PubMed ID: 10856568
[No Abstract] [Full Text] [Related]
53. Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells.
Xia CQ; Campbell KA; Clare-Salzler MJ
Curr Opin Organ Transplant; 2009 Aug; 14(4):338-43. PubMed ID: 19444106
[TBL] [Abstract][Full Text] [Related]
54. Lymphocytes treated by extracorporeal photopheresis demonstrate a drop in the Bcl-2/Bax ratio: a possible mechanism involved in extracorporeal-photopheresis-induced apoptosis.
Bladon J; Taylor PC
Dermatology; 2002; 204(2):104-7. PubMed ID: 11937734
[TBL] [Abstract][Full Text] [Related]
55. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
Darvay A; Salooja N; Russell-Jones R
J Eur Acad Dermatol Venereol; 2004 May; 18(3):279-84. PubMed ID: 15096136
[TBL] [Abstract][Full Text] [Related]
56. Pilot study of a new online extracorporeal photopheresis system in patients with steroid refractory or dependent chronic graft vs host disease.
Radwanski K; Burgstaler E; Weitgenant J; Dale H; Heber C; Winters J
J Clin Apher; 2020 Aug; 35(4):342-350. PubMed ID: 32640498
[TBL] [Abstract][Full Text] [Related]
57. An alternative for extracorporeal photopheresis: 8-methoxypsoralen and UVA-treated leucocytes from allogeneic donors improve graft-versus-host disease in mice.
Budde H; Papert S; Reichardt HM; Jarry H; Riggert J; Legler TJ
Vox Sang; 2018 Nov; 113(8):803-810. PubMed ID: 30353554
[TBL] [Abstract][Full Text] [Related]
58. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family.
Di Renzo M; Rubegni P; Sbano P; Cuccia A; Castagnini C; Pompella G; Pasqui AL; Capecchi PL; Auteri A; Laghi Pasini F; Fimiani M
Arch Dermatol Res; 2003 Sep; 295(5):175-82. PubMed ID: 12883827
[TBL] [Abstract][Full Text] [Related]
59. Extracorporeal photochemotherapy induces bona fide immunogenic cell death.
Tatsuno K; Yamazaki T; Hanlon D; Han P; Robinson E; Sobolev O; Yurter A; Rivera-Molina F; Arshad N; Edelson RL; Galluzzi L
Cell Death Dis; 2019 Aug; 10(8):578. PubMed ID: 31371700
[TBL] [Abstract][Full Text] [Related]
60. Extracorporeal photopheresis in Sézary syndrome. No significant effect in the survival of 44 patients with a peripheral blood T-cell clone.
Fraser-Andrews E; Seed P; Whittaker S; Russell-Jones R
Arch Dermatol; 1998 Aug; 134(8):1001-5. PubMed ID: 9722731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
